The global biopharmaceuticals market accounted for $ 160 billion in 2014, and it is expected to grow with a CAGR of 9.6% during 2015 – 2020, outpacing the global pharma market growth. Many biotech-derived drugs must be administered by injection using vials, cartridges or prefillable syringes as primary packaging containers. Claudia Petersen at Gerresheimer MDS explains why the specific needs of protein-based drug product formulations pose new challenges to the already existing primary packaging solutions.

Comments are closed.

%d bloggers like this: